Wegovy fuels sharp rise in use of weight-loss drugs for US youth
Public Health,Children,Obesity And Malnutrition
From the Center
AllSides Media Bias Rating: Center
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
News
Under-reported Stories About Gun Regulations, Trump’s War on Drugs, and Canada’s MAID Program Demand a Closer Look
Malayna J. Bizier
August 24th, 2026
Story of the Week
Dr. Fauci Pleads the Fifth
AllSides Staff
July 30th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
